Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01613014 · ClinicalTrials.gov registry record · Phase 2
ABT-436 for Alcohol Dependence
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT01613014 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 150 participants.
The verdict
NCT01613014, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The primary efficacy endpoint examines the hypothesis that ABT-436 will decrease the weekly percentage of heavy drinking days during Study Weeks 2 through 12 (Days 8-84) as compared to placebo. A "heavy drinking day" is 4 or more drinks per drinking day for women and 5 or more drinks per drinking day for men.
Interventions
- DRUG ABT-436
- DRUG Matched Placebo - Sugar Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01613014
The ClinicalTrials.gov registry entry for NCT01613014 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ABT-436 is the first listed.
NCT01613014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01613014 about?
NCT01613014 is a clinical study titled "ABT-436 for Alcohol Dependence". The primary efficacy endpoint examines the hypothesis that ABT-436 will decrease the weekly percentage of heavy drinking days during Study Weeks 2 through 12 (Days 8-84) as compared to placebo. A "heavy drinking day" is 4 or more drinks per drinking day for women and 5 or more drinks per drinking da...
What is the current status of trial NCT01613014?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2013-02. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01613014?
The interventions under investigation include: ABT-436 (DRUG), Matched Placebo - Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT01613014?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.